|
|
Blood, 15 March 2004, Vol. 103, No. 6, pp. 2363-2368.
Prepublished online as a Blood First Edition Paper on November 13, 2003; DOI 10.1182/blood-2002-11-3341.
Previous Article | Table of Contents | Next Article 
PHAGOCYTES
Ceramide inhibition of phospholipase D and its relationship to RhoA and ARF1 translocation in GTP S-stimulated polymorphonuclear leukocytes
Pamela J. Mansfield,
Shannon S. Carey,
Vania Hinkovska-Galcheva,
James A. Shayman, and
Laurence A. Boxer
From the Department of Pediatrics, Division of Hematology/Oncology, and the Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor.
Phospholipase D (PLD) regulates the polymorphonuclear leukocyte (PMN) functions of phagocytosis, degranulation, and oxidant production. Ceramide inhibition of PLD suppresses PMN function. In streptolysin Opermeabilized PMNs, PLD was directly activated by guanosine 5'-[gamma-thio]triphosphate (GTP S) stimulation of adenosine diphosphate (ADP)ribosylation factor (ARF) and Rho, stimulating release of lactoferrin from specific granules of permeabilized PMNs; PLD activation and degranulation were inhibited by C2-ceramide but not dihydro-C2-ceramide. To investigate the mechanism of ceramide's inhibitory effect on PLD, we used a cell-free system to examine PLD activity and translocation from cytosol to plasma membrane of ARF, protein kinase C (PKC) and , and RhoA, all of which can activate PLD. GTP S-activated cytosol stimulated PLD activity and translocation of ARF, PKC and , and RhoA when recombined with cell membranes. Prior incubation of PMNs with 10 µM C2-ceramide inhibited PLD activity and RhoA translocation, but not ARF1, ARF6, PKC , or PKC translocation. However, in intact PMNs stimulated with N-formyl-1-methionyl-1-leucyl-1-phenylalamine (FMLP) or permeabilized PMNs stimulated with GTP S, C2-ceramide did not inhibit RhoA translocation. Exogenous RhoA did not restore ceramide-inhibited PLD activity but bound to membranes despite ceramide treatment. These observations suggest that, although ceramide may affect RhoA in some systems, ceramide inhibits PLD through another mechanism, perhaps related to the ability of ceramide to inhibit phosphatidylinositol-bisphosphate (PIP2) interaction with PLD.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Gomez-Cambronero, M. Di Fulvio, and K. Knapek
Understanding phospholipase D (PLD) using leukocytes: PLD involvement in cell adhesion and chemotaxis
J. Leukoc. Biol.,
August 1, 2007;
82(2):
272 - 281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mebarek, H. Komati, F. Naro, C. Zeiller, M. Alvisi, M. Lagarde, A.-F. Prigent, and G. Nemoz
Inhibition of de novo ceramide synthesis upregulates phospholipase D and enhances myogenic differentiation
J. Cell Sci.,
February 1, 2007;
120(3):
407 - 416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Lehman, M. Di Fulvio, N. McCray, I. Campos, F. Tabatabaian, and J. Gomez-Cambronero
Phagocyte cell migration is mediated by phospholipases PLD1 and PLD2
Blood,
November 15, 2006;
108(10):
3564 - 3572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Olivera and J. Rivera
Sphingolipids and the Balancing of Immune Cell Function: Lessons from the Mast Cell
J. Immunol.,
February 1, 2005;
174(3):
1153 - 1158.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|